Serum interleukin-18 and tumor necrosis factor alpha in ankylosing spondylitis

被引：0
|
作者：
Zheng, DH [1 ]
Dal, L [1 ]
Wu, YM [1 ]
Han, ZJ [1 ]
机构：
[1] Zhongshan Univ, Affiliated Hosp 2, Dept Rheumatol, Guangzhou, Peoples R China
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：326 / +
页数：2
相关论文
共 50 条
  • [41] The Impact of Tumor Necrosis Factor α Inhibitors on Radiographic Progression in Ankylosing Spondylitis
    Haroon, Nigil
    Inman, Robert D.
    Learch, Thomas J.
    Weisman, Michael H.
    Lee, MinJae
    Rahbar, Mohammad H.
    Ward, Michael M.
    Reveille, John D.
    Gensler, Lianne S.
    ARTHRITIS AND RHEUMATISM, 2013, 65 (10): : 2645 - 2654
  • [42] Tuberculosis in patients with ankylosing spondylitis treated with anti tumor necrosis factor
    Kinikli, G.
    Kucuksahin, O.
    Turgay, M.
    Ates, A.
    Kinikli, S.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 355 - 355
  • [43] Serum Fetuin-a, Intercellular Adhesion Molecule-1 and Interleukin-18 Levels in Ankylosing Spondylitis and Psoriatic Arthritis.
    Przepiera-Bedzak, Hanna
    Fischer, Katarzyna
    Brzosko, Marek
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S706 - S706
  • [44] Elevated levels of interleukin-18 and tumor necrosis factor-α in serum of patients with type 2 diabetes mellitus:: Relationship with diabetic nephropathy
    Moriwaki, Y
    Yamamoto, T
    Shibutani, Y
    Aoki, E
    Tsutsumi, Z
    Takahashi, S
    Okamura, H
    Koga, M
    Fukuchi, M
    Hada, T
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52 (05): : 605 - 608
  • [45] Tumor Necrosis Factor (TNF)-alpha Promoter Polymorphisms in Ankylosing Spondylitis: Comment on the Article by Ji et al
    Zhongwen Chen
    Rui Ge
    Cell Biochemistry and Biophysics, 2014, 70 : 699 - 700
  • [46] Tumor Necrosis Factor (TNF)-alpha Promoter Polymorphisms in Ankylosing Spondylitis: Comment on the Article by Ji et al
    Chen, Zhongwen
    Ge, Rui
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2014, 70 (01) : 699 - 700
  • [47] TREATMENT OF ANKYLOSING SPONDYLITIS WITH TUMOR NECROSIS FACTOR-ALPHA INHIBITORS LOWERS THE RISK OF RENAL FUNCTION DECLINE
    Lee, S. J.
    Lee, J. S.
    Cha, U. C.
    Nam, E. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 731 - 731
  • [48] Gender Differences in Ankylosing Spondylitis: Men Derive Greater Benefit from Tumor Necrosis Factor Alpha Inhibitors
    Mandal, Jennifer
    Ward, Michael M.
    Weisman, Michael
    Simard, Jillian
    Brown, Matthew A.
    Lee, MinJae
    Rahbar, Mohammad H.
    Reveille, John D.
    Gensler, Lianne S.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [49] DIASTOLIC LEFT VENTRICULAR DYSFUNCTION IN ANKYLOSING SPONDYLITIS IMPROVES DURING TUMOR NECROSIS FACTOR ALPHA BLOCKING THERAPY
    Heslinga, S. C.
    Konings, T. C.
    Van der Horst-Bruinsma, I. E.
    Kamp, O.
    De Bruin-Bon, H. A.
    Van Halm, V. P.
    Peters, M. J.
    Nurmohamed, M. T.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 820 - 820
  • [50] EVALUATION OF THE EFFICACY OF INHIBITORS OF TUMOR NECROSIS FACTOR ALPHA FOR PATIENTS WITH ANKYLOSING SPONDYLITIS IN REAL CLINICAL PRACTICE.
    Rozochkina, E.
    Koltsova, E.
    Murtazalieva, D.
    Zhilyaev, E.
    Koshkarova, E.
    Lukina, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1511 - 1512
12345